A carregar...
A novel cell-penetrating peptide suppresses breast tumorigenesis by inhibiting β-catenin/LEF-1 signaling
The inhibition of β-catenin/LEF-1 signaling is an emerging strategy in cancer therapy. However, clinical targeted treatment of the β-catenin/LEF-1 complex remains relatively ineffective. Therefore, development of specific molecular targets is a key approach for identifying new cancer therapeutics. T...
Na minha lista:
Publicado no: | Sci Rep |
---|---|
Main Authors: | , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Nature Publishing Group
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4707489/ https://ncbi.nlm.nih.gov/pubmed/26750754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep19156 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|